Literature DB >> 11030333

TAC, a TBP-sans-TAFs complex containing the unprocessed TFIIAalphabeta precursor and the TFIIAgamma subunit.

D J Mitsiou1, H G Stunnenberg.   

Abstract

Transcription of TATA box-containing genes by RNA polymerase II is mediated by TBP-containing and TBP-free multisubunit complexes consisting of common and unique components. We have identified a highly stable TBP-TFIIA-containing complex, TAC, which is detectable in embryonal carcinoma (EC) cells but not in differentiated cells. TAC contains the TFIIAgamma subunit and the unprocessed form of TFIIAalphabeta, although the processed TFIIAalpha and TFIIAbeta subunits are present in EC cells. TAC mediates transcriptional activation by RNA polymerase II in vivo, even though it does not contain classical TAFs. Formaldehyde cross-linking revealed that in EC but not in differentiated cells, association of TBP with chromatin is strongly enhanced when complexed with TFIIA in vivo. Remarkably, the TFIIAalphabeta precursor is preferentially, if not exclusively, associated with chromatin as compared to the processed subunits present in "free" TFIIA in EC cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030333     DOI: 10.1016/s1097-2765(00)00052-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  19 in total

1.  A stable complex of a novel transcription factor IIB- related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements.

Authors:  M Teichmann; Z Wang; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Functional interaction between TATA and upstream CACGTG elements regulates the temporally specific expression of Otx mRNAs during early embryogenesis of the sea urchin, Hemicentrotus pulcherrimus.

Authors:  Akiko Kobayashi; Koji Akasaka; Masashi Kawaichi; Tetsuro Kokubo
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

Review 3.  The multicoloured world of promoter recognition complexes.

Authors:  Ferenc Müller; Làszlò Tora
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

4.  Cleavage and proteasome-mediated degradation of the basal transcription factor TFIIA.

Authors:  Torill Høiby; Dimitra J Mitsiou; Huiqing Zhou; Hediye Erdjument-Bromage; Paul Tempst; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

5.  Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery.

Authors:  Ronni Nielsen; Lars Grøntved; Hendrik G Stunnenberg; Susanne Mandrup
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

6.  Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.

Authors:  Shugaku Takeda; Satoru Sasagawa; Toshinao Oyama; Adam C Searleman; Todd D Westergard; Emily H Cheng; James J Hsieh
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

7.  Uncleaved TFIIA is a substrate for taspase 1 and active in transcription.

Authors:  Huiqing Zhou; Salvatore Spicuglia; James J-D Hsieh; Dimitra J Mitsiou; Torill Høiby; Gert Jan C Veenstra; Stanley J Korsmeyer; Hendrik G Stunnenberg
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  p300 is involved in formation of the TBP-TFIIA-containing basal transcription complex, TAC.

Authors:  Dimitra J Mitsiou; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

9.  Taspase1 processing alters TFIIA cofactor properties in the regulation of TFIID.

Authors:  Barbora Malecová; Valentina S Caputo; Diane F Lee; James J Hsieh; Thomas Oelgeschläger
Journal:  Transcription       Date:  2015

10.  TBP2 is a substitute for TBP in Xenopus oocyte transcription.

Authors:  Waseem Akhtar; Gert Jan C Veenstra
Journal:  BMC Biol       Date:  2009-08-03       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.